- Investing Ideas
- /
- U.S. Potentially Undervalued Companies
U.S. Potentially Undervalued Companies
UPDATED Apr 20, 2024
Companies with a Value score of at least 3, ordered by Value score
6,214 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
AKBA | US$1.36 | -6.8% | 106.0% | US$284.7m | US$5.00 | PS1.5x | E60.2% | n/a | Pharmaceuticals & Biotech | ||
ALXO | US$15.60 | 19.7% | 160.0% | US$782.4m | US$20.17 | PB4.1x | E11.5% | n/a | Pharmaceuticals & Biotech | ||
CANG | US$1.40 | -4.1% | 19.7% | US$188.2m | n/a | PB0.4x | n/a | 136.3% | Retail | ||
HI | US$48.02 | 2.5% | 4.4% | US$3.4b | US$63.00 | PE33.7x | E31.5% | 1.9% | Capital Goods | ||
LGDT.F | CA$0.27 | 11.6% | -34.1% | CA$126.0m | n/a | PB3.3x | E50.6% | n/a | Materials | ||
VMI | US$213.20 | -1.9% | -30.0% | US$4.3b | US$262.00 | PE30x | E38.9% | 1.1% | Capital Goods | ||
CACO | US$1.03 | 43.1% | 30.9% | US$54.4m | n/a | PE23.3x | n/a | n/a | Transportation | ||
SYK | US$325.43 | -4.9% | 7.2% | US$123.7b | US$365.69 | PE39.1x | E12.7% | 1.0% | Healthcare | ||
MAS | US$71.91 | -2.2% | 41.6% | US$15.8b | US$80.48 | PE17.4x | E5.5% | 1.6% | Capital Goods | ||
CPYY.Y | UK£6.52 | -1.8% | 15.0% | UK£7.0b | UK£8.56 | PE1.8x | E-41.4% | 3.0% | Utilities | ||
FC | US$39.48 | 1.4% | 4.7% | US$523.7m | US$63.33 | PE30.6x | E29.1% | n/a | Commercial Services | ||
STRM | US$0.33 | 0.3% | -81.3% | US$18.8m | US$1.25 | PB1x | E71.8% | n/a | Healthcare | ||
SCHY.Y | HK$23.02 | -16.0% | -38.6% | HK$145.7b | HK$38.34 | PE26.9x | E24.0% | 0% | Consumer Services | ||
PNW | US$74.40 | 3.0% | -7.7% | US$9.2b | US$75.92 | PE18.3x | E7.8% | 4.7% | Utilities | ||
DTM | US$63.23 | 0.9% | 29.6% | US$6.1b | US$60.80 | PE16x | E5.7% | 4.6% | Energy | ||
ECRT.F | CA$1.03 | -3.7% | -8.8% | CA$270.4m | CA$1.68 | PE-8.7x | E72.5% | n/a | Materials | ||
NUTX | US$0.70 | 4.0% | -93.0% | US$34.7m | US$6.00 | PB0.6x | E90.3% | n/a | Healthcare | ||
CRT | US$14.41 | 10.0% | -34.0% | US$86.5m | n/a | PE7.5x | n/a | 12.0% | Energy | ||
KROS | US$58.28 | -0.6% | 28.8% | US$2.1b | US$88.11 | PS13920.7x | E14.4% | n/a | Pharmaceuticals & Biotech | ||
CVI | US$32.82 | -6.6% | 21.2% | US$3.3b | US$32.20 | PE4.3x | E-43.5% | 13.7% | Energy | ||
QLYS | US$163.55 | -1.6% | 32.3% | US$6.0b | US$167.52 | PE39.9x | E6.9% | n/a | Software | ||
NTRA | US$85.28 | -9.7% | 54.6% | US$10.3b | US$102.65 | PS9.5x | E68.7% | n/a | Pharmaceuticals & Biotech | ||
HFFG | US$3.27 | 4.1% | -14.6% | US$170.6m | n/a | PB0.6x | n/a | n/a | Consumer Retailing | ||
OBK | US$29.16 | 2.8% | -9.5% | US$904.2m | US$35.60 | PB0.9x | E-0.6% | 2.1% | Banks |